ARMP Latest Press Releases

-- March 25, 2026 --

Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results PRNewswire 4:05 PM

-- March 19, 2026 --

Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update PRNewswire 7:00 AM

-- February 23, 2026 --

Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02 PRNewswire 7:00 AM

-- January 13, 2026 --

/C O R R E C T I O N -- Armata Pharmaceuticals, Inc./ PRNewswire 7:42 AM

Armata Pharmaceuticals Announces End-of-Phase 2 Meeting with FDA and Plans to Advance AP-SA02 to a Phase 3 Superiority Study in Complicated BacteremiaStaphylococcusaureus PRNewswire 7:00 AM

-- November 18, 2025 --

Armata Pharmaceuticals Announces Key Opinion Leader Webinar on S. aureus Bacteremia and AP-SA02 Hosted by Jones Research on November 25th at 10:00am EST PRNewswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software